Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Maia Biotechnology (AMEX:MAIA)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025

Plus de graphiques de la Bourse Maia Biotechnology

Maia Biotechnology (AMEX:MAIA)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025

Plus de graphiques de la Bourse Maia Biotechnology

Actualités Maia Biotechnology Inc

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 5 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 5 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Mercredi 5 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Lundi 3 Mars 2025 ( il y a 6 jours) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 27 Février 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients
Jeudi 27 Février 2025 ( il y a 1 semaine) • Business Wire

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
Mercredi 26 Février 2025 ( il y a 2 semaines) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 25 Février 2025 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 25 Février 2025 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 25 Février 2025 ( il y a 2 semaines) • Edgar (US Regulatory)

MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million
Lundi 24 Février 2025 ( il y a 2 semaines) • Business Wire

Form 8-K - Current report
Mercredi 19 Février 2025 ( il y a 3 semaines) • Edgar (US Regulatory)

Plus d'articles sur Maia Biotechnology Inc

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales